Rajasansir Medical Limited Company Accounts

RAJASANSIR MEDICAL LIMITED - Company Information

false false false false false false false false false true false false false false false false false No description of principal activity 2016-04-01 Sage Accounts Production Advanced 2017 Update 3 - FRS xbrli:pure xbrli:shares iso4217:GBP 08071750 2016-04-01 2017-03-31 08071750 2017-03-31 08071750 2016-03-31 08071750 2015-04-01 2016-03-31 08071750 2016-03-31 08071750 core:FurnitureFittings 2016-04-01 2017-03-31 08071750 bus:Director1 2016-04-01 2017-03-31 08071750 core:FurnitureFittings 2016-03-31 08071750 core:FurnitureFittings 2017-03-31 08071750 core:WithinOneYear 2017-03-31 08071750 core:WithinOneYear 2016-03-31 08071750 core:ShareCapital 2017-03-31 08071750 core:ShareCapital 2016-03-31 08071750 core:RetainedEarningsAccumulatedLosses 2017-03-31 08071750 core:RetainedEarningsAccumulatedLosses 2016-03-31 08071750 core:FurnitureFittings 2016-03-31 08071750 bus:Director1 2016-03-31 08071750 bus:Director1 2017-03-31 08071750 bus:Director1 2015-03-31 08071750 bus:Director1 2016-03-31 08071750 bus:Director1 2015-04-01 2016-03-31 08071750 bus:FRS102 2016-04-01 2017-03-31 08071750 bus:AuditExempt-NoAccountantsReport 2016-04-01 2017-03-31 08071750 bus:FullAccounts 2016-04-01 2017-03-31 08071750 bus:SmallCompaniesRegimeForAccounts 2016-04-01 2017-03-31 08071750 bus:PrivateLimitedCompanyLtd 2016-04-01 2017-03-31 08071750 core:OfficeEquipment 2016-04-01 2017-03-31 08071750 core:OfficeEquipment 2017-03-31 08071750 core:OfficeEquipment 2016-03-31

COMPANY REGISTRATION NUMBER: 08071750

Rajasansir Medical Limited

Filleted Unaudited Financial Statements

31 March 2017

Rajasansir Medical Limited

Financial Statements

Year ended 31 March 2017

Contents	Page

Statement of financial position	1

Notes to the financial statements	3

Rajasansir Medical Limited

Statement of Financial Position

31 March 2017

	2017		2016
Note	£	£	£

Fixed assets

Tangible assets	5		328	410

Current assets

Debtors	6	2,158	16,728
Cash at bank and in hand		155,560	134,824
		---------	---------
		157,718	151,552

Creditors: amounts falling due within one year	7	( 65,508)		( 81,247)
		---------		---------
Net current assets			92,210	70,305
			--------	--------
Total assets less current liabilities			92,538	70,715
			--------	--------
Net assets			92,538	70,715
			--------	--------

Capital and reserves

Called up share capital	4	4
Profit and loss account	92,534	70,711
	--------	--------
Shareholders funds	92,538	70,715
	--------	--------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 March 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Rajasansir Medical Limited

Statement of Financial Position (continued)

31 March 2017

These financial statements were approved by the board of directors and authorised for issue on 11 December 2017 , and are signed on behalf of the board by:

Dr J G S Rajasansir

Director

Company registration number: 08071750

Rajasansir Medical Limited

Notes to the Financial Statements

Year ended 31 March 2017

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 10-12, County End Business Centre, Oldham, Lancashire, OL4 4TZ, United Kingdom.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Transition to FRS 102

The entity transitioned from previous UK GAAP to FRS 102 as at 1 April 2015. Details of how FRS 102 has affected the reported financial position and financial performance is given in note 10.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable services rendered, stated net of discounts and of Value Added Tax.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Fixtures and fittings	-	20% reducing balance
Equipment	-	50% straight line

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 2 (2016: 2 ).

5. Tangible assets

	Fixtures and fittings	Equipment	Total
	£	£	£
Cost
At 1 April 2016 and 31 March 2017	1,000	5,687	6,687
	-------	-------	-------
Depreciation
At 1 April 2016	590	5,687	6,277
Charge for the year	82	–	82
	-------	-------	-------
At 31 March 2017	672	5,687	6,359
	-------	-------	-------
Carrying amount
At 31 March 2017	328	–	328
	-------	-------	-------
At 31 March 2016	410	–	410
	-------	-------	-------

6. Debtors

	2017	2016
	£	£
Trade debtors	–	14,726
Other debtors	2,158	2,002
	-------	--------
	2,158	16,728
	-------	--------

7. Creditors: amounts falling due within one year

	2017	2016
	£	£
Corporation tax	14,044	18,317
Social security and other taxes	3,625	4,824
Other creditors	47,839	58,106
	--------	--------
	65,508	81,247
	--------	--------

8. Directors' advances, credits and guarantees

During the year the directors entered into the following advances and credits with the company:

	2017
	Balance brought forward	Advances/ (credits) to the directors	Amounts repaid	Balance outstanding
	£	£	£	£
Dr J G S Rajasansir	( 56,606)	( 73,493)	84,110	( 45,989)
	--------	--------	--------	--------

	2016
	Balance brought forward	Advances/ (credits) to the directors	Amounts repaid	Balance outstanding
	£	£	£	£
Dr J G S Rajasansir	( 27,693)	( 76,713)	47,800	( 56,606)
	--------	--------	--------	--------

9. Related party transactions

The company was under the control of Dr J G S Rajasansir throughout the current period. Dr J G S Rajasansir is the managing director and majority shareholder. No transactions with related parties were undertaken such as are required to be disclosed under FRS102.

10. Transition to FRS 102

These are the first financial statements that comply with FRS 102. The company transitioned to FRS 102 on 1 April 2015.

No transitional adjustments were required in equity or profit or loss for the year.